Fig. 3From: Comparative safety of infliximab and adalimumab on pregnancy outcomes of women with inflammatory bowel diseases: a systematic review & meta-analysisRisk of APOs in pregnant women treated with infliximab and adalimumab for IBD (sensitivity analysis)Back to article page